Adherence to treatment in allergic rhinitis using mobile technology. the mask study

MASK group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

6 Downloads (Pure)

Resumé

Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12 143 users were registered. A total of 6 949 users reported at least one VAS data recording. Among them, 1 887 users reported ≥7 VAS data. About 1 195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR ≥70% and PDC ≤1.25), 51 (4.23%) were partly adherent (MPR ≥70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.

OriginalsprogEngelsk
TidsskriftClinical and Experimental Allergy
Vol/bind49
Udgave nummer4
Sider (fra-til)442-460
ISSN0954-7894
DOI
StatusUdgivet - apr. 2019

Fingeraftryk

Mobile Applications
Hypersensitivity
Cross-Sectional Studies

Bibliografisk note

© 2019 John Wiley & Sons Ltd.

Citer dette

@article{19ff7a29dd9d42afbb0855e36c875643,
title = "Adherence to treatment in allergic rhinitis using mobile technology. the mask study",
abstract = "Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12 143 users were registered. A total of 6 949 users reported at least one VAS data recording. Among them, 1 887 users reported ≥7 VAS data. About 1 195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28{\%}) users were adherent (MPR ≥70{\%} and PDC ≤1.25), 51 (4.23{\%}) were partly adherent (MPR ≥70{\%} and PDC = 1.50) and 176 (14.60{\%}) were switchers. On the other hand, 832 (69.05{\%}) users were non-adherent to medications (MPR <70{\%}). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68{\%}) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.",
keywords = "adherence, mHealth, mobile technology, observational study, rhinitis, treatment",
author = "E Menditto and E Costa and L Mid{\~a}o and S Bosnic-Anticevich and E Novellino and S Bialek and V Briedis and A Mair and R Rajabian-Soderlund and S Arnavielhe and A Bedbrook and W Czarlewski and I Annesi-Maesano and Anto, {J M} and P Devillier and {De Vries}, G and T Keil and A Sheikh and V Orlando and D Larenas-Linnemann and L Cecchi and {De Feo}, G and M Illario and C Stellato and J Fonseca and J Malva and M Morais-Almeida and Pereira, {A M} and A Todo-Bom and V Kvedariene and A Valiulis and Bergmann, {K C} and L Klimek and R M{\"o}sges and O Pfaar and T Zuberbier and V Cardona and J Mullol and Papadopoulos, {N G} and Prokopakis, {E P} and M Bewick and D Ryan and Roller-Wirnsberger, {R E} and Tomazic, {P V} and Cruz, {A A} and P Kuna and B Samolinski and Fokkens, {W J} and C Bindslev-Jensen and E Eller and {MASK group}",
note = "{\circledC} 2019 John Wiley & Sons Ltd.",
year = "2019",
month = "4",
doi = "10.1111/cea.13333",
language = "English",
volume = "49",
pages = "442--460",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "4",

}

Adherence to treatment in allergic rhinitis using mobile technology. the mask study. / MASK group.

I: Clinical and Experimental Allergy, Bind 49, Nr. 4, 04.2019, s. 442-460.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Adherence to treatment in allergic rhinitis using mobile technology. the mask study

AU - Menditto, E

AU - Costa, E

AU - Midão, L

AU - Bosnic-Anticevich, S

AU - Novellino, E

AU - Bialek, S

AU - Briedis, V

AU - Mair, A

AU - Rajabian-Soderlund, R

AU - Arnavielhe, S

AU - Bedbrook, A

AU - Czarlewski, W

AU - Annesi-Maesano, I

AU - Anto, J M

AU - Devillier, P

AU - De Vries, G

AU - Keil, T

AU - Sheikh, A

AU - Orlando, V

AU - Larenas-Linnemann, D

AU - Cecchi, L

AU - De Feo, G

AU - Illario, M

AU - Stellato, C

AU - Fonseca, J

AU - Malva, J

AU - Morais-Almeida, M

AU - Pereira, A M

AU - Todo-Bom, A

AU - Kvedariene, V

AU - Valiulis, A

AU - Bergmann, K C

AU - Klimek, L

AU - Mösges, R

AU - Pfaar, O

AU - Zuberbier, T

AU - Cardona, V

AU - Mullol, J

AU - Papadopoulos, N G

AU - Prokopakis, E P

AU - Bewick, M

AU - Ryan, D

AU - Roller-Wirnsberger, R E

AU - Tomazic, P V

AU - Cruz, A A

AU - Kuna, P

AU - Samolinski, B

AU - Fokkens, W J

AU - Bindslev-Jensen, C

AU - Eller, E

AU - MASK group

N1 - © 2019 John Wiley & Sons Ltd.

PY - 2019/4

Y1 - 2019/4

N2 - Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12 143 users were registered. A total of 6 949 users reported at least one VAS data recording. Among them, 1 887 users reported ≥7 VAS data. About 1 195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR ≥70% and PDC ≤1.25), 51 (4.23%) were partly adherent (MPR ≥70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.

AB - Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12 143 users were registered. A total of 6 949 users reported at least one VAS data recording. Among them, 1 887 users reported ≥7 VAS data. About 1 195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR ≥70% and PDC ≤1.25), 51 (4.23%) were partly adherent (MPR ≥70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting.

KW - adherence

KW - mHealth

KW - mobile technology

KW - observational study

KW - rhinitis

KW - treatment

U2 - 10.1111/cea.13333

DO - 10.1111/cea.13333

M3 - Journal article

C2 - 30597673

VL - 49

SP - 442

EP - 460

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 4

ER -